Arbutus Biopharma Corp
ABUSNasdaqCIK 1447028HealthcareFiscal year ends Dec 31
Reports and events: 561 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2016-08-0518:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-16-011536 |
| 2016-08-0417:21 ET | 10-Q | Quarterly reportPeriod 2016-06-30 | 0001628280-16-018534 |
| 2016-07-1917:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-16-011142 |
| 2016-07-1817:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-16-011128 |
| 2016-07-1418:22 ET | SC 13D | Ownership report, active investor | 0001193125-16-647461 |
| 2016-07-1317:23 ET | SC 13D | Ownership report, active investor | 0000903423-16-001151 |
| 2016-07-1317:16 ET | SC 13D | Ownership report, active investor | 0001144204-16-112848 |
| 2016-07-1316:46 ET | SC 13D | Ownership report, active investor | 0001104659-16-132418 |
| 2016-06-3008:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-16-010904 |
| 2016-06-0812:19 ET | 8-K | 1.01 Entry into a material agreement | 0000912282-16-000747 |
| 2016-06-0308:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-16-010457 |
| 2016-06-0108:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-16-010408 |
| 2016-05-2514:08 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000912282-16-000733 |
| 2016-05-0416:07 ET | 10-Q | Quarterly reportPeriod 2016-03-31 | 0001628280-16-015493 |
| 2016-05-0416:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-16-009680 |
| 2016-05-0316:54 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-16-009641 |
| 2016-04-2908:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-16-009506 |
| 2016-04-2713:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-16-009422 |
| 2016-04-2514:20 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000912282-16-000695 |
| 2016-04-2208:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-16-009327 |
| 2016-04-1408:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-16-009153 |
| 2016-04-0818:51 ET | DEF 14A | Proxy statementPeriod 2016-05-19 | 0001628280-16-014088 |
| 2016-03-3014:21 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-16-008914 |
| 2016-03-1119:44 ET | 10-K/A | Annual report, amendedPeriod 2015-12-31 | 0001628280-16-012607 |
| 2016-03-0913:47 ET | 10-K | Annual reportPeriod 2015-12-31 | 0001628280-16-012462 |
| 2016-03-0908:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-16-008459 |
| 2016-03-0808:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-16-008433 |
| 2016-03-0317:29 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-16-008346 |
| 2016-02-1714:09 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-16-097653 |
| 2016-02-1717:34 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-16-465765 |
| 2016-02-0416:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-16-007660 |
| 2016-01-1106:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-16-007123 |
| 2015-11-0517:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-15-006068 |
| 2015-11-0516:37 ET | 10-Q | Quarterly reportPeriod 2015-09-30 | 0001062993-15-005809 |
| 2015-10-2808:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-15-005748 |
| 2015-10-1508:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-15-005543 |
| 2015-10-0713:00 ET | 8-K | 1.02 Termination of a material agreement | 0001171843-15-005432 |
| 2015-10-0608:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-15-005414 |
| 2015-10-0110:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-15-005376 |
| 2015-09-0917:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-15-005097 |
| 2015-08-2508:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-15-004875 |
| 2015-08-0716:39 ET | 10-Q | Quarterly reportPeriod 2015-06-30 | 0001171843-15-004476 |
| 2015-08-0708:50 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-15-004467 |
| 2015-08-0516:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-15-004369 |
| 2015-08-0308:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-15-004256 |
| 2015-08-0306:57 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-15-004252 |
| 2015-07-2008:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-15-003907 |
| 2015-07-1617:26 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors | 0000912282-15-000243 |
| 2015-07-1516:05 ET | 10-Q/A | Quarterly report, amendedPeriod 2015-03-31 | 0001171843-15-003849 |
| 2015-07-1411:30 ET | 8-K | 5.07 Shareholder vote results | 0001171843-15-003813 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 17:55 ET. Listed shows no prices and gives no investment advice.